Global ENG(Endoglin precursor) Market Insights, Forecast to 2025
- QYR2772573
- 145 Pages
- September 2018
- Medical Devices
This research report categorizes the global ENG(Endoglin precursor) market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.
In 2017, the global ENG(Endoglin precursor) market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the ENG(Endoglin precursor) market based on company, product type, application and key regions.
The various contributors involved in the value chain of ENG(Endoglin precursor) include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the ENG(Endoglin precursor) include
Aviva Systems Biology Corporation(USA)
Atlas Antibodies(Sweden)
Abbexa Ltd(UK)
Abiocode(US)
Boster Biological Technology(USA)
Biobyt(UK)
Bio-Rad(US)
Bioss Antibodies(US)
Biosensis(US)
BioLegend(US)
BioVision(US)
BethylLaboratories(US)
Epigentek(US)
EnzoLifeSciences(Switzerland)
Genetex(US)
Lifespan Biosciences(US)
Novus Biologicals(US)
Proteintech(US)
ProSci(US)
ProteoGenix(France)
R&D Systems(US)
Rockland(US)
St John's Laboratory Ltd(UK)
Stemcell(Canada)
Thermo Fisher Scientific(US)
USBiological(US)
Market Size Split by Type
Above 90%
Above 95%
Above 99%
Others
Market Size Split by Application
Biopharmaceutical Companies
Hospitals
Bioscience Research Institutions
Others
Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global ENG(Endoglin precursor) market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of ENG(Endoglin precursor) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global ENG(Endoglin precursor) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the ENG(Endoglin precursor) with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of ENG(Endoglin precursor) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of ENG(Endoglin precursor) are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of ENG(Endoglin precursor) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Study Coverage
1.1 ENG(Endoglin precursor) Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global ENG(Endoglin precursor) Market Size Growth Rate by Type
1.4.2 Above 90%
1.4.3 Above 95%
1.4.4 Above 99%
1.4.5 Others
1.5 Market by Application
1.5.1 Global ENG(Endoglin precursor) Market Size Growth Rate by Application
1.5.2 Biopharmaceutical Companies
1.5.3 Hospitals
1.5.4 Bioscience Research Institutions
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global ENG(Endoglin precursor) Market Size
2.1.1 Global ENG(Endoglin precursor) Revenue 2016-2025
2.1.2 Global ENG(Endoglin precursor) Sales 2016-2025
2.2 ENG(Endoglin precursor) Growth Rate by Regions
2.2.1 Global ENG(Endoglin precursor) Sales by Regions
2.2.2 Global ENG(Endoglin precursor) Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 ENG(Endoglin precursor) Sales by Manufacturers
3.1.1 ENG(Endoglin precursor) Sales by Manufacturers
3.1.2 ENG(Endoglin precursor) Sales Market Share by Manufacturers
3.1.3 Global ENG(Endoglin precursor) Market Concentration Ratio (CR5 and HHI)
3.2 ENG(Endoglin precursor) Revenue by Manufacturers
3.2.1 ENG(Endoglin precursor) Revenue by Manufacturers (2016-2018)
3.2.2 ENG(Endoglin precursor) Revenue Share by Manufacturers (2016-2018)
3.3 ENG(Endoglin precursor) Price by Manufacturers
3.4 ENG(Endoglin precursor) Manufacturing Base Distribution, Product Types
3.4.1 ENG(Endoglin precursor) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers ENG(Endoglin precursor) Product Category
3.4.3 Date of International Manufacturers Enter into ENG(Endoglin precursor) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global ENG(Endoglin precursor) Sales by Type
4.2 Global ENG(Endoglin precursor) Revenue by Type
4.3 ENG(Endoglin precursor) Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global ENG(Endoglin precursor) Breakdown Data by Application
6 North America
6.1 North America ENG(Endoglin precursor) by Countries
6.1.1 North America ENG(Endoglin precursor) Sales by Countries
6.1.2 North America ENG(Endoglin precursor) Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America ENG(Endoglin precursor) by Type
6.3 North America ENG(Endoglin precursor) by Application
6.4 North America ENG(Endoglin precursor) by Company
7 Europe
7.1 Europe ENG(Endoglin precursor) by Countries
7.1.1 Europe ENG(Endoglin precursor) Sales by Countries
7.1.2 Europe ENG(Endoglin precursor) Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe ENG(Endoglin precursor) by Type
7.3 Europe ENG(Endoglin precursor) by Application
7.4 Europe ENG(Endoglin precursor) by Company
8 Asia Pacific
8.1 Asia Pacific ENG(Endoglin precursor) by Countries
8.1.1 Asia Pacific ENG(Endoglin precursor) Sales by Countries
8.1.2 Asia Pacific ENG(Endoglin precursor) Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific ENG(Endoglin precursor) by Type
8.3 Asia Pacific ENG(Endoglin precursor) by Application
8.4 Asia Pacific ENG(Endoglin precursor) by Company
9 Central & South America
9.1 Central & South America ENG(Endoglin precursor) by Countries
9.1.1 Central & South America ENG(Endoglin precursor) Sales by Countries
9.1.2 Central & South America ENG(Endoglin precursor) Revenue by Countries
9.1.3 Brazil
9.2 Central & South America ENG(Endoglin precursor) by Type
9.3 Central & South America ENG(Endoglin precursor) by Application
9.4 Central & South America ENG(Endoglin precursor) by Company
10 Middle East and Africa
10.1 Middle East and Africa ENG(Endoglin precursor) by Countries
10.1.1 Middle East and Africa ENG(Endoglin precursor) Sales by Countries
10.1.2 Middle East and Africa ENG(Endoglin precursor) Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa ENG(Endoglin precursor) by Type
10.3 Middle East and Africa ENG(Endoglin precursor) by Application
10.4 Middle East and Africa ENG(Endoglin precursor) by Company
11 Company Profiles
11.1 Aviva Systems Biology Corporation(USA)
11.1.1 Aviva Systems Biology Corporation(USA) Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of ENG(Endoglin precursor)
11.1.4 ENG(Endoglin precursor) Product Description
11.1.5 Recent Development
11.2 Atlas Antibodies(Sweden)
11.2.1 Atlas Antibodies(Sweden) Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of ENG(Endoglin precursor)
11.2.4 ENG(Endoglin precursor) Product Description
11.2.5 Recent Development
11.3 Abbexa Ltd(UK)
11.3.1 Abbexa Ltd(UK) Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of ENG(Endoglin precursor)
11.3.4 ENG(Endoglin precursor) Product Description
11.3.5 Recent Development
11.4 Abiocode(US)
11.4.1 Abiocode(US) Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of ENG(Endoglin precursor)
11.4.4 ENG(Endoglin precursor) Product Description
11.4.5 Recent Development
11.5 Boster Biological Technology(USA)
11.5.1 Boster Biological Technology(USA) Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of ENG(Endoglin precursor)
11.5.4 ENG(Endoglin precursor) Product Description
11.5.5 Recent Development
11.6 Biobyt(UK)
11.6.1 Biobyt(UK) Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of ENG(Endoglin precursor)
11.6.4 ENG(Endoglin precursor) Product Description
11.6.5 Recent Development
11.7 Bio-Rad(US)
11.7.1 Bio-Rad(US) Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of ENG(Endoglin precursor)
11.7.4 ENG(Endoglin precursor) Product Description
11.7.5 Recent Development
11.8 Bioss Antibodies(US)
11.8.1 Bioss Antibodies(US) Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of ENG(Endoglin precursor)
11.8.4 ENG(Endoglin precursor) Product Description
11.8.5 Recent Development
11.9 Biosensis(US)
11.9.1 Biosensis(US) Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of ENG(Endoglin precursor)
11.9.4 ENG(Endoglin precursor) Product Description
11.9.5 Recent Development
11.10 BioLegend(US)
11.10.1 BioLegend(US) Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of ENG(Endoglin precursor)
11.10.4 ENG(Endoglin precursor) Product Description
11.10.5 Recent Development
11.11 BioVision(US)
11.12 BethylLaboratories(US)
11.13 Epigentek(US)
11.14 EnzoLifeSciences(Switzerland)
11.15 Genetex(US)
11.16 Lifespan Biosciences(US)
11.17 Novus Biologicals(US)
11.18 Proteintech(US)
11.19 ProSci(US)
11.20 ProteoGenix(France)
11.21 R&D Systems(US)
11.22 Rockland(US)
11.23 St John's Laboratory Ltd(UK)
11.24 Stemcell(Canada)
11.25 Thermo Fisher Scientific(US)
11.26 USBiological(US)
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key ENG(Endoglin precursor) Raw Material
13.1.2 ENG(Endoglin precursor) Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
Figure Picture of ENG(Endoglin precursor)
Figure Global ENG(Endoglin precursor) Production (MT) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global ENG(Endoglin precursor) Production Market Share by Types (Product Category) in 2017
Figure Above 90% Product Picture
Table Major Manufacturers of Above 90%
Figure Above 95% Product Picture
Table Major Manufacturers of Above 95%
Figure Above 99% Product Picture
Table Major Manufacturers of Above 99%
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global ENG(Endoglin precursor) Market Size Growth Rate by Application 2018-2025 (MT)
Figure Biopharmaceutical Companies
Figure Hospitals
Figure Bioscience Research Institutions
Figure Others
Figure ENG(Endoglin precursor) Report Years Considered
Figure Global ENG(Endoglin precursor) Market Size 2016-2025 (Million US$)
Figure Global ENG(Endoglin precursor) Sales 2016-2025 (MT)
Table Global ENG(Endoglin precursor) Market Size by Regions 2016-2025 (MT) & (Million US$)
Table Global ENG(Endoglin precursor) Sales by Regions 2016-2025 (MT)
Table Global ENG(Endoglin precursor) Sales Market Share by Regions 2016-2025
Figure Global ENG(Endoglin precursor) Sales Market Share by Regions 2016-2025
Figure 2017 Global ENG(Endoglin precursor) Sales Market Share by Regions
Table Global ENG(Endoglin precursor) Revenue by Regions 2016-2025 (Million US$)
Table Global ENG(Endoglin precursor) Revenue Market Share by Regions 2016-2025
Figure Global ENG(Endoglin precursor) Revenue Market Share by Regions 2016-2025
Figure 2017 Global ENG(Endoglin precursor) Revenue Market Share by Regions
Table Global ENG(Endoglin precursor) Sales by Manufacturers (2016-2018) (MT)
Table Global ENG(Endoglin precursor) Sales Share by Manufacturers (2016-2018)
Figure Global ENG(Endoglin precursor) Sales Share by Manufacturers in 2017
Table ENG(Endoglin precursor) Revenue by Manufacturers (2016-2018) (Million US$)
Table ENG(Endoglin precursor) Revenue Share by Manufacturers (2016-2018)
Figure ENG(Endoglin precursor) Value Share by Manufacturers in 2017
Table Global ENG(Endoglin precursor) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers ENG(Endoglin precursor) Price (2016-2018) (USD/Kg)
Table ENG(Endoglin precursor) Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers ENG(Endoglin precursor) Product Category
Table Date of International Manufacturers Enter into ENG(Endoglin precursor) Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global ENG(Endoglin precursor) Sales by Type (2016-2025) (MT)
Table Global ENG(Endoglin precursor) Sales Share by Type (2016-2025)
Figure Global ENG(Endoglin precursor) Sales Market Share by Type (2016-2025)
Figure Global ENG(Endoglin precursor) Sales Market Share by Type in 2017
Table Global ENG(Endoglin precursor) Revenue by Type (2016-2025) (Million US$)
Table Global ENG(Endoglin precursor) Revenue Share by Type (2016-2025)
Figure Global ENG(Endoglin precursor) Revenue Market Share by Type (2016-2025)
Figure Global ENG(Endoglin precursor) Revenue Market Share by Type in 2017
Table ENG(Endoglin precursor) Price by Type 2013-2018 (USD/Kg)
Table Global ENG(Endoglin precursor) Sales by Application (2016-2025) (MT)
Table Global ENG(Endoglin precursor) Sales Share by Application (2016-2025)
Figure Global Sales ENG(Endoglin precursor) Market Share by Application (2016-2025)
Figure Global Sales ENG(Endoglin precursor) Market Share by Application (2016-2025)
Figure North America ENG(Endoglin precursor) Sales Growth Rate 2016-2025 (MT)
Figure North America ENG(Endoglin precursor) Revenue Growth Rate 2016-2025 (Million US$)
Table North America ENG(Endoglin precursor) Sales by Countries (2016-2025) (MT)
Table North America ENG(Endoglin precursor) Sales Market Share by Countries (2016-2025)
Figure 2017 North America ENG(Endoglin precursor) Sales Market Share by Countries
Table North America ENG(Endoglin precursor) Revenue by Countries (2016-2025) (Million US$)
Table North America ENG(Endoglin precursor) Revenue Market Share by Countries (2016-2025)
Figure 2017 North America ENG(Endoglin precursor) Revenue Market Share by Countries
Figure United States ENG(Endoglin precursor) Sales Growth Rate (2016-2025) (MT)
Figure United States ENG(Endoglin precursor) Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada ENG(Endoglin precursor) Sales Growth Rate (2016-2025) (MT)
Figure Canada ENG(Endoglin precursor) Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico ENG(Endoglin precursor) Sales Growth Rate (2016-2025) (MT)
Figure Mexico ENG(Endoglin precursor) Revenue Growth Rate (2016-2025) (Million US$)
Table North America ENG(Endoglin precursor) Sales by Type (2016-2025) (MT)
Table North America ENG(Endoglin precursor) Sales Market Share by Type (2016-2025)
Figure 2017 North America ENG(Endoglin precursor) Market Share by Type
Table North America ENG(Endoglin precursor) Sales by Application (2016-2025) (MT)
Table North America ENG(Endoglin precursor) Sales Market Share by Application (2016-2025)
Figure 2017 North America ENG(Endoglin precursor) Market Share by Application
Table North America ENG(Endoglin precursor) Sales by Company (2016-2018) (MT)
Table North America ENG(Endoglin precursor) Sales Market Share by Company (2016-2018)
Figure North America ENG(Endoglin precursor) Sales Market Share by Company in 2017
Figure Europe ENG(Endoglin precursor) Sales Growth Rate 2016-2025 (MT)
Figure Europe ENG(Endoglin precursor) Revenue Growth Rate 2016-2025 (Million US$)
Table Europe ENG(Endoglin precursor) Sales by Countries (2016-2025) (MT)
Table Europe ENG(Endoglin precursor) Sales Market Share by Countries (2016-2025)
Figure 2017 Europe ENG(Endoglin precursor) Sales Market Share by Countries
Table Europe ENG(Endoglin precursor) Revenue by Countries (2016-2025) (Million US$)
Table Europe ENG(Endoglin precursor) Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe ENG(Endoglin precursor) Revenue Market Share by Countries
Figure Germany ENG(Endoglin precursor) Sales Growth Rate (2016-2025) (MT)
Figure Germany ENG(Endoglin precursor) Revenue Growth Rate (2016-2025) (MT)
Figure France ENG(Endoglin precursor) Sales Growth Rate (2016-2025) (MT)
Figure France ENG(Endoglin precursor) Revenue Growth Rate (2016-2025) (MT)
Figure UK ENG(Endoglin precursor) Sales Growth Rate (2016-2025) (MT)
Figure UK ENG(Endoglin precursor) Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy ENG(Endoglin precursor) Sales Growth Rate (2016-2025) (MT)
Figure Italy ENG(Endoglin precursor) Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia ENG(Endoglin precursor) Sales Growth Rate (2016-2025) (MT)
Figure Russia ENG(Endoglin precursor) Revenue Growth Rate (2016-2025) (Million US$)
Table Europe ENG(Endoglin precursor) Sales by Type (2016-2025) (MT)
Table Europe ENG(Endoglin precursor) Sales Market Share by Type (2016-2025)
Figure 2017 Europe ENG(Endoglin precursor) Market Share by Type
Table Europe ENG(Endoglin precursor) Sales by Application (2016-2025) (MT)
Table Europe ENG(Endoglin precursor) Sales Market Share by Application (2016-2025)
Figure 2017 Europe ENG(Endoglin precursor) Market Share by Application
Table Europe ENG(Endoglin precursor) Sales by Company (2016-2018) (MT)
Table Europe ENG(Endoglin precursor) Sales Market Share by Company (2016-2018)
Figure Europe ENG(Endoglin precursor) Sales Market Share by Company in 2017
Figure Asia Pacific ENG(Endoglin precursor) Sales Growth Rate 2016-2025 (MT)
Figure Asia Pacific ENG(Endoglin precursor) Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific ENG(Endoglin precursor) Sales by Countries (2016-2025) (MT)
Table Asia Pacific ENG(Endoglin precursor) Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific ENG(Endoglin precursor) Sales Market Share by Countries
Table Asia Pacific ENG(Endoglin precursor) Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific ENG(Endoglin precursor) Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific ENG(Endoglin precursor) Revenue Market Share by Countries
Figure China ENG(Endoglin precursor) Sales Growth Rate (2016-2025) (MT)
Figure China ENG(Endoglin precursor) Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan ENG(Endoglin precursor) Sales Growth Rate (2016-2025) (MT)
Figure Japan ENG(Endoglin precursor) Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea ENG(Endoglin precursor) Sales Growth Rate (2016-2025) (MT)
Figure Korea ENG(Endoglin precursor) Revenue Growth Rate (2016-2025) (Million US$)
Figure India ENG(Endoglin precursor) Sales Growth Rate (2016-2025) (MT)
Figure India ENG(Endoglin precursor) Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia ENG(Endoglin precursor) Sales Growth Rate (2016-2025) (MT)
Figure Australia ENG(Endoglin precursor) Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia ENG(Endoglin precursor) Sales Growth Rate (2016-2025) (MT)
Figure Indonesia ENG(Endoglin precursor) Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia ENG(Endoglin precursor) Sales Growth Rate (2016-2025) (MT)
Figure Malaysia ENG(Endoglin precursor) Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines ENG(Endoglin precursor) Sales Growth Rate (2016-2025) (MT)
Figure Philippines ENG(Endoglin precursor) Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand ENG(Endoglin precursor) Sales Growth Rate (2016-2025) (MT)
Figure Thailand ENG(Endoglin precursor) Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam ENG(Endoglin precursor) Sales Growth Rate (2016-2025) (MT)
Figure Vietnam ENG(Endoglin precursor) Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore ENG(Endoglin precursor) Sales Growth Rate (2016-2025) (MT)
Figure Singapore ENG(Endoglin precursor) Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific ENG(Endoglin precursor) Sales by Type (2016-2025) (MT)
Table Asia Pacific ENG(Endoglin precursor) Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific ENG(Endoglin precursor) Market Share by Type
Table Asia Pacific ENG(Endoglin precursor) Sales by Application (2016-2025) (MT)
Table Asia Pacific ENG(Endoglin precursor) Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific ENG(Endoglin precursor) Market Share by Application
Table Asia Pacific ENG(Endoglin precursor) Sales by Company (2016-2018) (MT)
Table Asia Pacific ENG(Endoglin precursor) Sales Market Share by Company (2016-2018)
Figure Asia Pacific ENG(Endoglin precursor) Sales Market Share by Company in 2017
Figure Central & South America ENG(Endoglin precursor) Sales Growth Rate 2016-2025 (MT)
Figure Central & South America ENG(Endoglin precursor) Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America ENG(Endoglin precursor) Sales by Countries (2016-2025) (MT)
Table Central & South America ENG(Endoglin precursor) Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America ENG(Endoglin precursor) Sales Market Share by Countries
Table Central & South America ENG(Endoglin precursor) Revenue by Countries (2016-2025) (Million US$)
Table Central & South America ENG(Endoglin precursor) Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America ENG(Endoglin precursor) Revenue Market Share by Countries
Figure Brazil ENG(Endoglin precursor) Sales Growth Rate (2016-2025) (MT)
Figure Brazil ENG(Endoglin precursor) Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina ENG(Endoglin precursor) Sales Growth Rate (2016-2025) (MT)
Figure Argentina ENG(Endoglin precursor) Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America ENG(Endoglin precursor) Sales by Type (2016-2025) (MT)
Table Central & South America ENG(Endoglin precursor) Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America ENG(Endoglin precursor) Market Share by Type
Table Central & South America ENG(Endoglin precursor) Sales by Application (2016-2025) (MT)
Table Central & South America ENG(Endoglin precursor) Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America ENG(Endoglin precursor) Market Share by Application
Table Central & South America ENG(Endoglin precursor) Sales by Company (2016-2018) (MT)
Table Central & South America ENG(Endoglin precursor) Sales Market Share by Company (2016-2018)
Figure Central & South America ENG(Endoglin precursor) Sales Market Share by Company in 2017
Figure Middle East and Africa ENG(Endoglin precursor) Sales Growth Rate 2016-2025 (MT)
Figure Middle East and Africa ENG(Endoglin precursor) Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa ENG(Endoglin precursor) Sales by Countries (2016-2025) (MT)
Table Middle East and Africa ENG(Endoglin precursor) Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa ENG(Endoglin precursor) Sales Market Share by Countries
Table Middle East and Africa ENG(Endoglin precursor) Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa ENG(Endoglin precursor) Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa ENG(Endoglin precursor) Revenue Market Share by Countries
Figure GCC Countries ENG(Endoglin precursor) Sales Growth Rate (2016-2025) (MT)
Figure GCC Countries ENG(Endoglin precursor) Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey ENG(Endoglin precursor) Sales Growth Rate (2016-2025) (MT)
Figure Turkey ENG(Endoglin precursor) Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt ENG(Endoglin precursor) Sales Growth Rate (2016-2025) (MT)
Figure Egypt ENG(Endoglin precursor) Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa ENG(Endoglin precursor) Sales Growth Rate (2016-2025) (MT)
Figure South Africa ENG(Endoglin precursor) Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa ENG(Endoglin precursor) Sales by Type (2016-2025) (MT)
Table Middle East and Africa ENG(Endoglin precursor) Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa ENG(Endoglin precursor) Market Share by Type
Table Middle East and Africa ENG(Endoglin precursor) Sales by Application (2016-2025) (MT)
Table Middle East and Africa ENG(Endoglin precursor) Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa ENG(Endoglin precursor) Market Share by Application
Table Middle East and Africa ENG(Endoglin precursor) Sales by Company (2016-2018) (MT)
Table Middle East and Africa ENG(Endoglin precursor) Sales Market Share by Company (2016-2018)
Figure Middle East and Africa ENG(Endoglin precursor) Sales Market Share by Company in 2017
Table Aviva Systems Biology Corporation(USA) Company Details
Table Aviva Systems Biology Corporation(USA) ENG(Endoglin precursor) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Aviva Systems Biology Corporation(USA) Recent Development
Table Atlas Antibodies(Sweden) Company Details
Table Atlas Antibodies(Sweden) ENG(Endoglin precursor) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Atlas Antibodies(Sweden) Recent Development
Table Abbexa Ltd(UK) Company Details
Table Abbexa Ltd(UK) ENG(Endoglin precursor) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Abbexa Ltd(UK) Recent Development
Table Abiocode(US) Company Details
Table Abiocode(US) ENG(Endoglin precursor) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Abiocode(US) Recent Development
Table Boster Biological Technology(USA) Company Details
Table Boster Biological Technology(USA) ENG(Endoglin precursor) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Boster Biological Technology(USA) Recent Development
Table Biobyt(UK) Company Details
Table Biobyt(UK) ENG(Endoglin precursor) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Biobyt(UK) Recent Development
Table Bio-Rad(US) Company Details
Table Bio-Rad(US) ENG(Endoglin precursor) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Bio-Rad(US) Recent Development
Table Bioss Antibodies(US) Company Details
Table Bioss Antibodies(US) ENG(Endoglin precursor) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Bioss Antibodies(US) Recent Development
Table Biosensis(US) Company Details
Table Biosensis(US) ENG(Endoglin precursor) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Biosensis(US) Recent Development
Table BioLegend(US) Company Details
Table BioLegend(US) ENG(Endoglin precursor) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table BioLegend(US) Recent Development
Table BioVision(US) Company Details
Table BethylLaboratories(US) Company Details
Table Epigentek(US) Company Details
Table EnzoLifeSciences(Switzerland) Company Details
Table Genetex(US) Company Details
Table Lifespan Biosciences(US) Company Details
Table Novus Biologicals(US) Company Details
Table Proteintech(US) Company Details
Table ProSci(US) Company Details
Table ProteoGenix(France) Company Details
Table R&D Systems(US) Company Details
Table Rockland(US) Company Details
Table St John's Laboratory Ltd(UK) Company Details
Table Stemcell(Canada) Company Details
Table Thermo Fisher Scientific(US) Company Details
Table USBiological(US) Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table ENG(Endoglin precursor) Value Chain
Table Typical Suppliers of Key ENG(Endoglin precursor) Raw Material
Table ENG(Endoglin precursor) Customers List
Table ENG(Endoglin precursor) Sales Channels
Table ENG(Endoglin precursor) Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
